Pathophysiological Hypothesis of COVID-19 Psychosis.
Journal
The Journal of nervous and mental disease
ISSN: 1539-736X
Titre abrégé: J Nerv Ment Dis
Pays: United States
ID NLM: 0375402
Informations de publication
Date de publication:
01 Dec 2023
01 Dec 2023
Historique:
medline:
29
11
2023
pubmed:
28
11
2023
entrez:
28
11
2023
Statut:
ppublish
Résumé
In December 2019, a new coronavirus called SARS-CoV-2 was discovered in patients with pneumonia of unknown cause. Although respiratory symptoms mainly characterize infection by this virus, neuropsychiatric manifestations of the disease are becoming more and more frequent. Among them, the appearance of psychotic outbreaks in patients experiencing the infection or after a short time after it has resolved is remarkable. This narrative review aims to describe the possible relationship between SARS-CoV-2 and the onset of psychosis by developing the neurotropic capacities of the virus and analyzing the neurobiology of psychoses.
Identifiants
pubmed: 38015184
doi: 10.1097/NMD.0000000000001624
pii: 00005053-202312000-00003
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
890-895Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Références
Achar A, Ghosh C (2020) COVID-19–associated neurological disorders: The potential route of CNS invasion and blood-brain barrier relevance. Cell. 9:2360.
APA (American Psychiatry Association) Dictionary of psychology. 2021 Available at: https://dictionary.apa.org/psychosis. Accessed March 20, 2021.
Baig AM, Khaleeq A, Ali U, Syeda H (2020) Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Nerosci. 11:995–998.
Barrantes FJ (2020) Central nervous system targets and routes for SARS-CoV-2: Current views and new hypotheses. ACS Chem Nerosci. 11:2793–2803.
Barron H, Hafizi S, Andreazza AC, Mizrahi R (2018) Neuroinflammation and oxidative stress in psychosis and psychosis risk. Int J Mol Sci. 18:651.
Cannon TD (2016) Brain biomarkers of vulnerability and progression to psychosis. Schizophr Bull. 42 Suppl 1(suppl 1):S127–S132.
Chacko M, Job A, Caston F, George P, Yacoub A, Cáceda R (2020) COVID-19–induced psychosis and suicidal behavior: Case report. SN Compr Clin Med. 2:2391–2395.
Davies J, Randeva HS, Chatha K, Hall M, Spandidos DA, Karteris E, Kyrou I (2020) Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19. Mol Med Rep. 22:4221–4226.
De Felice F, Tovar-Moll F, Moll J, Munoz DP, Ferreira ST (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the central nervous system. Trends Neurosci. 43:355–357.
de Sousa Moreira JL, Barbosa SMB, Vieira JG, Chaves NCB, Felix EBG, Feitosa PWG, da Cruz IL, da Silva CGL, Neto MLR (2021) The psychiatric and neuropsychiatric repercussions associated with severe infections of COVID-19 and other coronaviruses. Prog Neuropsychopharmacol Biol Psychiatry. 106:110159.
Dubovsky AN, Arvikar S, Stern TA, Axelrod L (2021) The neuropsychiatric complications of glucocorticoid use: Steroid psychosis revisited. Psychosomatics. 53:103–115.
Elmi S, Sahu G, Malavade K, Jacob T (2019) Role of tissue plasminogen activator and plasminogen activator inhibitor as potential biomarkers in psychosis. Asian J Psychiatr. 43:105–110.
Eloge JC, Ross DA, Cooper JJ (2020) Afflicted by the gods: The shared history and neurobiology of psychosis and epilepsy. Biol Psychiatry. 87:e35–e36.
Fraguas D, Díaz-Caneja CM, Ayora M, Hernández-Álvarez F, Rodríguez-Quiroga A, Recio S, Leza JC, Arango C (2019) Oxidative stress and inflammation in first-episode psychosis: A systematic review and Meta-analysis. Schizophr Bull. 45:742–751.
Gaebel W, Zielasek J (2015) Focus on psychosis. Dialogues Clin Neurosci. 17:9–18.
Garro MF, Duarte JM, Iérmoli RH (2020) Coagulopatía por SARS-CoV-2. Prensa Med Argent. 106:575–587.
Heneka MT, Golenbock D, Latz E, Morgan D, Brown R (2020) Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther. 12:69.
Herazo-Bustos M, Aparicio-Turbay S, Patarroyo Edith L (2016) Trastorno psicótico inducido por glucocorticoides: Descripción de 2 casos clínicos y revisión de la literatura. Psiquiatri Biol. 23:40–43.
Hoirisch-Clapauch S, Amaral OB, Mezzasalma MA, Panizzutti R, Nardi AE (2016) Dysfunction in the coagulation system and schizophrenia. Transl Psychiatry. 6:e704.
Jarrahi A, Ahluwalia M, Khodadadi H, da Silva Lopes Salles E, Kolhe R, Hess DC, Vale F, Kumar M, Baban B, Vaibhav K, Dhandapani KM (2020) Neurological consequences of COVID-19: What have we learned and where do we go from here?J Neuroinflammation. 17:286.
Juncal Ruiz M (2018) Respuesta inmunoinflamatoria sistémica en primeros episodios de psicosis. [Doctora]. Cantabria, Spain: Universidad de Cantabria.
Khandaker GM, Cousins L, Deakin J, Lennox BR, Yolken R, Jones PB (2015) Inflammation and immunity in schizophrenia: Implications for pathophysiology and treatment. Lancet Psychiatry. 2:258–270.
Kopczynska M, Zelek W, Touchard S, Gaughran F, Di Forti M, Mondelli V, Murray R, O'Donovan MC, Morgan BP (2019) Complement system biomarkers in first episode psychosis. Schizophr Res. 204:16–22.
Kozato N, Mishra M, Firdosi M (2021) New-onset psychosis due to COVID-19. BMJ Case Rep. 14:e242538.
Kulaga SS, Miller CWT (2021) Viral respiratory infections and psychosis: A review of the literature and the implications of COVID-19. Neurosci Biobehav Rev. 127:520–530.
Laskaris L, Zalesky A, Weickert CS, Di Biase MA, Gursharan C, Baune BT, Bousman C, Nelson B, McGorry P, Everall I, Pantelis C, Cropley V (2019) Investigation of peripheral complement factors across stages of psychosis. Schizophr Res. 204:30–37.
Lieberman JA, Sheitman BB, Kinon BJ (1997) Neurochemical sensitization in the pathophysiology of schizophrenia: Deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology. 17:205–229.
Makivic N, Stöllberger C, Schauer D, Bernhofer L, Pawelka E, Erfurth A, Weidinger F (2021) Pulmonary embolism and acute psychosis, a case report of an outpatient with a mild course of COVID-19 [published online ahead of print, 2021 Apr 27. SN Compr Clin Med. 3:1434–1439.
Mighdoll MI, Tao R, Kleinman JE, Hyde TM (2015) Myelin, myelin-related disorders, and psychosis. Schizophr Res. 161:85–93.
Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B (2011) Meta-analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects. Biol Psychiatry. 70:663–671.
Mirza J, Ganguly A, Ostrovskaya A, Tusher A, Viswanathan R (2020) Command suicidal hallucination as initial presentation of coronavirus disease 2019 (COVID-19): A case report. Psychosomatics. 61:561–564.
Pacheco-Herrero M, Soto-Rojas LO, Harrington CR, Flores-Martinez YM, Villegas-Rojas MM, León-Aguilar AM, Martínez-Gómez PA, Campa-Córdoba BB, Apátiga-Pérez R, Corniel-Taveras CN, Dominguez-García JJ, Blanco-Alvarez VM, Luna-Muñoz J (2021) Elucidating the neuropathologic mechanisms of SARS-CoV-2 infection. Front Neurol. 12:660087.
Pantelis C, Jayaram M, Hannan AJ, Wesselingh R, Nithianantharajah J, Wannan CMJ, Syeda WT, Choy KHC, Zantomio D, Christopoulos A, Velakoulis D, O'Brien TJ (2021) Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19. Aust N Z J Psychiatry. 55:750–762.
Park S, Miller BJ (2020) Meta-analysis of cytokine and C-reactive protein levels in high-risk psychosis. Schizophr Res. 226:5–12.
Parker C, Slan A, Shalev D, Critchfield A (2021) Abrupt late-onset psychosis as a presentation of coronavirus 2019 disease (COVID-19): A longitudinal case report. J Psychiatr Pract. 27:131–136.
Parra A, Juanes A, Losada CP, Álvarez-Sesmero S, Santana VD, Martí I, Urricelqui J, Rentero DP (2020) Psychotic symptoms in COVID-19 patients. A retrospective descriptive study. Psychiatry Res. 291:113254.
Paybast S, Emami A, Koosha M, Baghalha F (2020) Novel coronavirus disease (COVID-19) and central nervous system complications: What neurologist need to know. Acta Neurol Taiwan. 29:24–31.
Payus AO, Liew Sat Lin C, Mohd Noh M, Jeffree MS, Ali RA (2020) SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease-(COVID-19). Bosn J of Basic Med Sci. 20:283–292.
Pennisi M, Lanza G, Falzone L, Fisicaro F, Ferri R, Bella R (2020) SARS-CoV-2 and the nervous system: From clinical features to molecular mechanisms. Int J Mol Sci. 21:54–75.
Ramírez-Jirano LJ, Velasco-Ramírez SF, Pérez-Carranza GA, Domínguez-Díaz C, Bitzer-Quintero OK (2019) Citocinas y sistema nervioso: Relación con la esquizofrenia. Rev Med Inst Mex Seguro Soc. 57:107–112.
Sánchez García MD, Pecino Esquerdo B, Pérez Martínez E (2015) Manía inducida por el tratamiento con corticoesteroides: Revisión a partir de un caso clínico. Rev Asoc Esp Neuropsiq. 35:323–340.
Sepehrinezhad A, Shahbazi A, Negah SS (2020) COVID-19 virus may have neuroinvasive potential and cause neurological complications: A perspective review. J Neurovirol. 26:324–329.
Severance EG, Dickerson FB, Viscidi RP, Bossis J, Stallings CR, Origoni AE, Sullens A, Yolken RH (2011) Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptoms. Schizophr Bull. 37:101–107.
Siever LJ, Davis KL (2004) The pathophysiology of schizophrenia disorders: Perspectives from the spectrum. Am J Psychiatry. 161:398–413.
Sinanović O, Muftić M, Sinanović S (2020) COVID-19 pandemia: Neuropsychiatric comorbidity and consequences. Psychiatr Danub. 32:236–244.
Soria V, Uribe J, Salvat-Pujol N, Palao D, Menchón JM, Labad J (2018) Psychoneuroimmunology of mental disorders. Rev Psiquiatr Salud Ment (Engl Ed). 11:115–124.
Stahl SM (2018) Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: Dopamine, serotonin, and glutamate. CNS Spectr. 23:187–191.
Steardo L Jr, Steardo L, Verkhratsky A (2020) Psychiatric face of COVID-19. Transl Psychiatry. 10:261.
Stojanovic A, Martorell L, Montalvo I, Ortega L, Monseny R, Vilella E, Labad J (2014) Increased serum interleukin-6 levels in early stages of psychosis: Associations with at-risk mental states and the severity of psychotic symptoms. Psychoneuroendocrinology. 41:23–32.
Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ (2021) 6-Month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry. 8:416–427.
Taylor SF, Grove TB, Ellingrod VL, Tso IF (2019) The fragile brain: Stress vulnerability, negative affect and GABAergic neurocircuits in psychosis. Schizophr Bull. 45:1170–1183.
Troyer EA, Kohn JN, Hong S (2020) Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun. 87:34–39.
Tsamakis K, Triantafyllis AS, Tsiptsios D, Spartalis E, Mueller C, Tsamakis C, Chaidou S, Spandidos DA, Fotis L, Economou M, Rizos M (2020) COVID-19 related stress exacerbates common physical and mental pathologies and affects treatment (review). Exp Ther Med. 20:159–162.
van Berckel BN, Bossong MG, Boellaard R, Kloet R, Schuitemaker A, Caspers E, Luurtsema G, Windhorst AD, Cahn W, Lammertsma AA, Kahn RS (2008) Microglia activation in recent-onset schizophrenia: A quantitative (R)-[11C]PK11195 positron emission tomography study. Biol Psychiatry. 64:820–822.
Yachou Y, El Idrissi A, Belapasov V, Benali SA (2020) Neuroinvasion, neurotropic and neuroinflammatory events of SARS-CoV-2: Understanding the neurological manifestations in COVID-19 patients. Neurol Sci. 41:2657–2669.
Yapici-Eser H, Koroglu YE, Oztop-Cakmak O, Keskin O, Gursoy A, Gursoy-Ozdemir Y (2021) Neuropsychiatric symptoms of COVID-19 explained by SARS-CoV-2 proteins' mimicry of human protein interactions. Front Hum Neurosci. 15:656313.
Zandifar A, Badrfam R, Yazdani S, Arzaghi SM, Rahimi F, Ghasemi S, Khamisabadi S, Khonsari NM, Qorbani M (2020) Prevalence and severity of depression, anxiety, stress and perceived stress in hospitalized patients with COVID-19 [published online ahead of print, 2020 Oct 29]. J Diabetes Metab Disord. 19:1–8.
Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W, Si H, Zhu Y, Li B, Huang C, Chen H, Chen J, Luo Y, Guo H, Jiang R, Liu M, Chen Y, Shen X, Wang X, Zheng X, Zhao K, Chen Q, Deng F, Liu L, Yan B, Zhan F, Wang Y, Xiao G, Shi Z (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 579:270–273.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 382:727–733.